Suzhou Pudee is a small and below-the-radar company that has been engaged in the research and development of advanced single molecules for nearly twenty years.

Since 2021, we started to focused on the research and development of Electronic chemicals and Aroma chemicals, Especially photoresist materials and Perfume & Fragrance materials.the electronic chemicals are used in Photoresist,MOF,COF,OLED etc. the Aroma chemicals are used in advanced professional perfumery and Personal care & Household care industry.

Presently we have developed more than two hundred kind of performance single molecules, most of them are top quality and the cost is very reasonable and acceptable.in the fields of electronic chemicals and Aroma chemicals, we aim to play a qualified small role in the future manufacturing and supply chain.

Nilotinib is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. it was developed based on the structure of the Abl-imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr-Abl kinase inhibitor that is 10-30 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl expressing cells.

It is approved by FDA- (29 October 2007), EMA- (29 September 2009), MHRA- (19 November 2007) and TGA- (17 January 2008) for use as a treatment for Philadelphia Chromosome (Ph+)-positive Chronic myelogenous leukaemia. on April 11, 2011, Novartis announced that it is discontinuing a Phase III trial of Tasigna® (nilotinib) for investigational use in the first-line treatment of gastrointestinal stromal tumor(GIST) based on the recommendation of an independent data monitoring committee.

We provide the key intermediate (641571-11-1) and API, white to off-white powder,

the purity is more than 99.5%(HPLC).

Top quality, more competitive price.

NMR,HPLC,IR,MOA,COA are available,

Special packing is offered.